Rapid RV/LV vs iCAC Device
AI Verdict
Choose Rapid RV/LV if…
Choose Rapid RV/LV if your primary need is the rapid, AI-powered assessment of pulmonary embolism severity from CTPA scans. This tool is ideal for emergency departments and critical care settings where quick and objective measurement of right and left ventricle ratios is crucial for patient triage and guiding immediate treatment decisions for suspected or confirmed PE.
View Rapid RV/LV →Choose iCAC Device if…
Choose iCAC Device if your goal is opportunistic screening for cardiovascular disease by detecting and quantifying coronary artery calcium from routine, non-contrast chest CT scans. This tool is best suited for identifying patients at risk for coronary artery disease from existing imaging data, allowing for proactive risk stratification and earlier intervention in a broader patient population.
View iCAC Device →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Rapid RV/LV | iCAC Device |
|---|---|---|
| Pricing | Contact vendor for pricing information. | Contact for pricing |
| Deployment | Unknown | Software as a Medical Device (SaMD), integrates with PACS or DICOM router. Cloud-based (via Carebricks platform). |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Rapid RV/LVRapid RV/LV emphasizes rapid results, triage, and notification capabilities through its integrated platform, including mobile and web apps, for acute care scenarios. This focus on immediate, coordinated communication for critical decision-making suggests a highly dynamic and responsive user experience. While iCAC also offers seamless integration, its primary focus is on opportunistic detection rather than acute response.
Clinical Value
TieBoth tools offer significant and distinct clinical value. Rapid RV/LV provides rapid assessment of pulmonary embolism severity, aiding in faster triage and treatment for an acute, life-threatening condition. The iCAC Device enables opportunistic detection and quantification of coronary artery calcium from routine scans, facilitating early intervention for chronic cardiovascular disease and potentially reducing long-term costs. Both are FDA-cleared and address critical needs in cardiovascular care.
Pricing & Value
TieBoth Rapid RV/LV and iCAC Device require contacting the vendor for pricing information, making a direct comparison of their cost-effectiveness impossible. However, both offer substantial value through improved clinical outcomes, enhanced efficiency, and potential cost savings in their respective domains of acute care and opportunistic screening.
Enterprise Readiness
Rapid RV/LVRapidAI explicitly states its HIPAA compliance and BAA availability in the structured facts, which are crucial for enterprise adoption. Furthermore, its extensive deployment in thousands of hospitals across over 100 countries and flexible on-premises or hybrid deployment options demonstrate proven scalability and robust infrastructure for enterprise environments. While Bunkerhill Health integrates with PACS/DICOM and EHRs, its compliance details are listed as 'contact vendor for details'.
Innovation
iCAC DeviceThe iCAC Device's innovation lies in its ability to opportunistically detect and quantify coronary artery calcium from routine, non-contrast, non-gated chest CT scans, leveraging existing data for early disease detection without requiring additional dedicated imaging. This proactive approach to identifying at-risk individuals from incidental findings represents a significant advancement in preventive care and population health management. Rapid RV/LV's automation of RV/LV ratio measurement is also innovative but addresses a more focused acute care workflow.
Support & Docs
Rapid RV/LVRapidAI offers comprehensive support, including 24/7/365 customer service via email and phone, extensive online resources like webinars, case studies, and guides, and a formal 'Advanced Training Certification Program' with CE credits. Bunkerhill Health's publicly available information on support and documentation is less detailed, primarily consisting of news, case studies, and a workflow library.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Rapid RV/LV | iCAC Device |
|---|---|---|
| Tool Name | Rapid RV/LV | iCAC Device |
| Company | RapidAI (formerly iSchemaView) | Bunkerhill Health |
| Primary Clinical Focus | Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. | Detects and quantifies coronary artery calcium from routine, non-contrast, non-gated chest CT scans, aiding in early cardiovascular disease detection. |
| Input Scan Type | CTPA scans | Routine, non-contrast, non-gated chest CT scans |
| Key Output/Measurement | Automated measurement of right and left ventricle diameters, calculation of RV/LV ratio, annotated images showing ventricular measurements. | Estimates presence and quantity of coronary artery calcium (CAC), visual representation of estimated CAC segmentation, exact and four-category quantitative estimates of CAC burden in Agatston units. |
| Specialties Supported | Cardiology, Pulmonology, Radiology | Cardiology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Rapid RV/LV and iCAC Device.